Tetraspanins
-
Subject Areas on Research
- Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
- Anti-CD37 chimeric antigen receptor T cells are active against B- and T-cell lymphomas.
- Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
- Bacterial penetration of bladder epithelium through lipid rafts.
- DNA Methylation Analysis Identifies Loci for Blood Pressure Regulation.
- Expression of tetraspanins NET-6 and CD151 in breast cancer as a potential tumor biomarker.
- Foxp1 Is Indispensable for Ductal Morphogenesis and Controls the Exit of Mammary Stem Cells from Quiescence.
- Identification of metastasis-associated breast cancer genes using a high-resolution whole genome profiling approach.
- Maternal genotype and gestational diabetes.
- Novel Genetic Loci Associated With Retinal Microvascular Diameter.
- TM4SF20 ancestral deletion and susceptibility to a pediatric disorder of early language delay and cerebral white matter hyperintensities.
- TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
- Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia.
- Tetraspanin CD37 protects against the development of B cell lymphoma.
- The tetraspanin superfamily member NET-6 is a new tumor suppressor gene.